BACKGROUND Familial prostate cancer (CaP) accounts for 15–20% of all CaP, and
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …

The incidence of prostate cancer (CaP) and its increase in the last 10 years vary both from
country to country and according to the ethnic group, with the highest incidence reported for …

Purpose: We review the current epidemiological and genetic knowledge regarding
hereditary prostate cancer, and outline its clinical implications. Materials and Methods …

Although all men are at increased risk for prostate cancer developing with increasing age, a
family history of prostate cancer in a first-degree relative multiplies that risk approximately …

The aim of this study was to characterize the pathological features of hereditary prostate
cancer, a recently recognized variant of prostate cancer with an autosomal dominant …

PURPOSE: A family history of prostate cancer is an important risk factor for this disease. The
clinical presentation and prognosis of familial disease remain uncertain. In this study these …

OBJECTIVES: To compare the clinical and biologic features at diagnosis between sporadic
and familial clinically localized prostate cancer (CaP), and to compare the prognosis of …

Purpose: We analyzed the outcome after radical prostatectomy of patients with familial
prostate cancer versus patients with sporadic prostate cancer. Materials and Methods: The …

Abstract Study Type-Aetiology (cohort) Level of Evidence 2b OBJECTIVE• To describe
clinical and histopathological characteristics of Finnish familial prostate cancer (PCa) …

BACKGROUND Although all men age> 50 years are at an increased risk for the
development of prostate carcinoma, 2 major factors increase this risk: family history and …